Literature DB >> 23079900

Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports.

C Aumeran1, P Guyot, M Boisnoir, C Robin-Hennequin, M Vidal, C Forestier, O Traore, O Lesens.   

Abstract

Vancomycin lock solution (LS) is recommended for the conservative treatment of subcutaneous injection port (SIP)-related infections, but may be associated with failure. We used an in vitro dynamic model of biofilm formation in an SIP, based on a continuous flow circulating via a real SIP, to assess the effectiveness of vancomycin (5 mg/ml), daptomycin (5 mg/ml) and ethanol 40 % LS in eradicating a pre-established Staphylococcus epidermidis biofilm. Heparin, Ringer's lactate and enoxaparin sodium LS were used as controls. The logarithmic reductions of colony-forming units (CFU) were compared by Student's t-test. After 24 h of exposure, the vancomycin LS did not exert a greater bactericidal effect than the heparin LS control (mean logarithmic reduction: 2.27 ± 0.58 vs. 1.34 ± 0.22, respectively, p = 0.3). The mean logarithmic reduction was greater with daptomycin LS (5.45 ± 0.14 vs. 0.39 ± 0.12, p < 0.01) and ethanol LS (6.79 ± 1.03 vs. 1.43 ± 0.54, p = 0.02). Bacterial revival after exposure to 24 h of LS was assessed. The mean viable bacteria count was significantly higher for vancomycin LS (9.36 ± 0.10 log(10)CFU) and daptomycin LS (9.16 ± 0.02 log(10)CFU) than for ethanol LS (2.95 ± 1.65 log(10)CFU). Ethanol appeared to be the most attractive option to treat SIP-related infection, but its poor ability to entirely disrupt the biofilm structure may require its use in association with a dispersal agent to avoid renewal of the biofilm.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079900     DOI: 10.1007/s10096-012-1732-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Assessment on experimental bacterial biofilms and in clinical practice of the efficacy of sampling solutions for microbiological testing of endoscopes.

Authors:  C Aumeran; E Thibert; F A Chapelle; C Hennequin; O Lesens; O Traoré
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

2.  Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence.

Authors:  Amos Adler; Isaac Yaniv; Ester Solter; Enrique Freud; Zmira Samra; Jerry Stein; Salvador Fisher; Itzhak Levy
Journal:  J Pediatr Hematol Oncol       Date:  2006-01       Impact factor: 1.289

3.  Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.

Authors:  J Fortún; F Grill; P Martín-Dávila; J Blázquez; M Tato; J Sánchez-Corral; L García-San Miguel; S Moreno
Journal:  J Antimicrob Chemother       Date:  2006-08-08       Impact factor: 5.790

4.  XTT assay for evaluating the effect of alcohols, hydrogen peroxide and benzalkonium chloride on biofilm formation of Staphylococcus epidermidis.

Authors:  Kamel Chaieb; Tarek Zmantar; Yosra Souiden; Kacem Mahdouani; Amina Bakhrouf
Journal:  Microb Pathog       Date:  2010-11-18       Impact factor: 3.738

5.  Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.

Authors:  Nathan P Wiederhold; Elizabeth A Coyle; Issam I Raad; Randall A Prince; Russell E Lewis
Journal:  J Antimicrob Chemother       Date:  2005-04-06       Impact factor: 5.790

Review 6.  Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.

Authors:  Rodney M Donlan
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

7.  In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.

Authors:  Kerry L LaPlante; Leonard A Mermel
Journal:  Nephrol Dial Transplant       Date:  2007-04-01       Impact factor: 5.992

8.  Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.

Authors:  Nuria Fernandez-Hidalgo; Benito Almirante; Raquel Calleja; Isabel Ruiz; Ana M Planes; Dolors Rodriguez; Carles Pigrau; Albert Pahissa
Journal:  J Antimicrob Chemother       Date:  2006-04-05       Impact factor: 5.790

9.  Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain?

Authors:  Issam Raad; Rawan Kassar; Dany Ghannam; Anne Marie Chaftari; Ray Hachem; Ying Jiang
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

10.  In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.

Authors:  Ji-Young Lee; Kwan Soo Ko; Kyong Ran Peck; Won Sup Oh; Jae-Hoon Song
Journal:  J Antimicrob Chemother       Date:  2006-03-23       Impact factor: 5.790

View more
  4 in total

1.  In Vitro Approach for Identification of the Most Effective Agents for Antimicrobial Lock Therapy in the Treatment of Intravascular Catheter-Related Infections Caused by Staphylococcus aureus.

Authors:  S Hogan; M Zapotoczna; N T Stevens; H Humphreys; J P O'Gara; E O'Neill
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  Sanitizing Effect of Ethanol Against Biofilms Formed by Three Gram-Negative Pathogenic Bacteria.

Authors:  Han-Saem Park; Youngseok Ham; Keum Shin; Yeong-Suk Kim; Tae-Jong Kim
Journal:  Curr Microbiol       Date:  2015-05-05       Impact factor: 2.188

Review 3.  Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.

Authors:  Matteo Vassallo; Brigitte Dunais; Pierre-Marie Roger
Journal:  Infection       Date:  2015-02-06       Impact factor: 3.553

4.  In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

Authors:  Diego Parra; Alejandro Peña-Monje; Nieves María Coronado-Álvarez; José Hernández-Quero; Jorge Parra-Ruiz
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.